Investors say drug pricing measure may shift incentives for biotech venture funding

Wall Street Journal

2 December 2021 - Some analysts say bill would discourage investment in drugs taken as pills.

Democratic drug-pricing measures passed by the House may steer more venture-capital funding to biological medicines, a field already drawing significant investor attention, some investors and analysts said.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing , Investment